NelsonKEVlahovDSolomonLCohnSMunozA. Temporal trends of incident human immunodeficiency virus infection in a cohort of injection drug users in Baltimore, Maryland. Arch Intern Med1995; 155:1305–11.
2.
DiazTChuSYByersRHJrHershBSContiLRietmeijerCA, The types of drugs used by HIV-infected injection drug users in a multistate surveillance project: implications for intervention. Am J Public Health1994; 84:1971–5.
3.
VlahovDAnthonyJCCelentanoDSolomonLChowdhuryN. Trend of HIV −1 risk reduction among initiates into intravenous drug use 1982–1987. Am J Drug Alcohol Abuse1991; 17:39–48.
4.
GarfeinRSVlahovDGalaiNDohertyMCNelsonKE. Viral infections in short-term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency virus, and human T-lymphotropic viruses. Am J Public Health1996; 86:655–61.
5.
FullerCVlahovDOmpadDShahNArriaAMStrathdeeSA. High risk behaviors associated with transition from illicit non-injection to injection drug use: a case-control study. Drug Alcohol Depend. In press2002.
